Crizanlizumab-tmca Ka pahu kui

Anter

• Ma mua o ka hoʻohana ʻana i ka crizanlizumab-tmca injection,
• Crizanlizumab-tmca injection hiki ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

Hoʻohana ʻia ʻo Crizanlizumab-tmca injection e hōʻemi i ka nui o nā ʻehaʻeha (hikiwawe, ʻehaʻeha hiki ke hala i mau hola i kekahi mau lā) i nā mākua a me nā keiki 16 mau makahiki a ʻoi paha me ka maʻi maʻi maʻi maʻi. Aia ʻo Crizanlizumab-tmca i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ka pale ʻana i kekahi mau huna koko mai ka launa pū ʻana.

Hoʻokomo ʻia ʻo Crizanlizumab-tmca ʻāpana ma ke ʻano he solution (wai) e hoʻokomo ʻiʻo ʻia (i loko o kahi aa) e ke kauka a kahu wahine paha ma kahi o 30 mau minuke. Hāʻawi pinepine ʻia hoʻokahi manawa i kēlā me kēia 2 mau pule no nā mahele mua ʻelua a laila hoʻokahi manawa i kēlā me kēia 4 mau pule.

Hiki iā Crizanlizumab-tmca injection ke hana i nā hopena infusion koʻikoʻi, i loko o 24 mau hola o ka loaʻa ʻana o kahi lāʻau. E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa nei ka infusion a ma hope o ka hoʻopili ʻana e ʻike pono ʻaʻole ʻoe i kahi hopena koʻikoʻi i ka lāʻau. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e haʻi koke aku i kāu kauka a kahu paha: ka fiva, ke anuanu, ka lū ʻana, ka luaʻi, ka luhi, ka poni ʻana, ka hou ʻana, ka ʻeha, ka hives, ka ʻume, ka huehue ʻana, a me ka paʻakikī o ka hanu ʻana.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka hoʻohana ʻana i ka crizanlizumab-tmca injection,

• e haʻi i kāu kauka a me ka mea kauka lāʻau inā he maʻi ʻoe i ka crizanlizumab-tmca, i nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka crizanlizumab-tmca injection. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, lawe ʻoe a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka hoʻohana ʻana i ka crizanlizumab-tmca injection, e kāhea i kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai kahi infusion crizanlizumab-tmca, e kāhea koke i kāu kauka.

Crizanlizumab-tmca injection hiki ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• nausea
• ʻeha hope a hui pū paha
• fiva
• ʻulaʻula, ʻeha, pehu, a puhi paha i ka pūnaewele kahi i hāʻawi ʻia ai ka ʻume

Crizanlizumab-tmca injection hiki ke hana i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i nā manawa a pau me kāu kauka a me ka hale hana.

Ma mua o ka loaʻa ʻana o kahi hoʻokolohua hoʻokolohua, e haʻi i kāu kauka a me nā limahana o ke keʻena hoʻokolohua ke loaʻa nei iā ʻoe ʻo crizanlizumab-tmca.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i crizanlizumab-tmca.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Adakveo^®